Atlas FDA

VYSIS ALK BREAK APART FISH PROBE KIT

FDA premarket approval P110012/S013 · decided 2017-04-12

Approval details

PMA number
P110012
Supplement
S013
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VYSIS ALK BREAK APART FISH PROBE KIT
Generic name
Fluorescence in situ hybridization, anaplastic lymphoma kinase, gene rearrangement
Applicant
Abbott Molecular, Inc.
Date received
2016-11-22
Decision date
2017-04-12
Days to decision
141 days
Decision code
APPR
Product code
OWE
Advisory committee
Pathology
Expedited review
No
Location
Des Plaines, IL
Statement
Approval for upgrades to the VP 2000 Processor.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Alinity m HCV (K252102)Abbott Molecular, Inc.2025-09-25
Alinity m EBV (09N43-095) (K243489)Abbott Molecular, Inc.2025-07-28
Alinity m CMV (K243485)Abbott Molecular, Inc.2025-07-01
Alinity m BKV (K241921)Abbott Molecular, Inc.2025-03-24
Alinity m Resp-4-Plex (K241573)Abbott Molecular, Inc.2025-02-14
Alinity m HSV 1 & 2 / VZV (K233349)Abbott Molecular, Inc.2024-05-03
Alinity m STI Assay (K222379)Abbott Molecular, Inc.2023-03-03
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778)Abbott Molecular, Inc.2022-07-15